Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

β-Catenin regulates the expression of tenascin-C in human colorectal tumors

Oncogene volume 24, pages 8200–8204 (2005)Cite this article

Abstract

Tenascin-C (TN-C) is a component of the extracellular matrix (ECM). It is expressed during development and re-expressed in many types of cancers, where it is involved in the modulation of adhesion and proliferation. TN-C expression is especially high at sites of epithelial mesenchymal transition (EMT), which are found frequently at the invasion front of well-differentiated human colorectal adenocarcinomas. Tumor cells in this compartment are characterized by a strong nuclear expression of the oncogenic transcription factor β-catenin. Here, we demonstrate that TN-C is a β-catenin target gene in human colorectal tumors. Thus, by far the most common mutations in colorectal tumors, found in the Wnt-signaling pathway and leading to the stabilizing of β-catenin, might influence invasion by altering adhesive properties and EMT of tumor cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  • Barker N, Huls G, Korinek V and Clevers H . (1999). Am. J. Pathol., 154, 29–35.

  • Barker N, Hurlstone A, Musisi H, Miles A, Bienz M and Clevers H . (2001). EMBO J., 20, 4935–4943.

  • Ben-Ze’ev A and Geiger B . (1998). Curr. Opin. Cell Biol., 10, 629–639.

  • Bienz M and Clevers H . (2000). Cell, 103, 311–320.

  • Brabletz T, Jung A, Hermann K, Gunther K, Hohenberger W and Kirchner T . (1998). Pathol. Res. Pract., 194, 701–704.

  • Brabletz T, Jung A and Kirchner T . (2002). Virchows. Arch., 441, 1–11.

  • Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, Knuechel R and Kirchner T . (2001). Proc. Natl. Acad. Sci. USA, 98, 10356–10361.

  • Brembeck FH, Schwarz-Romond T, Bakkers J, Wilhelm S, Hammerschmidt M and Birchmeier W . (2004). Genes Dev., 18, 2225–2230.

  • Chiquet-Ehrismann R and Chiquet M . (2003). J. Pathol., 200, 488–499.

  • Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P and Ben-Ze’ev A . (2003). J. Cell Biol., 163, 847–857.

  • Hanamura N, Yoshida T, Matsumoto E, Kawarada Y and Sakakura T . (1997). Int. J. Cancer, 73, 10–15.

  • He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW . (1998). Science, 281, 1509–1512.

  • Hiendlmeyer E, Regus S, Wassermann S, Hlubek F, Haynl A, Dimmler A, Koch C, Knoll C, van Beest M, Reuning U, Brabletz T, Kirchner T and Jung A . (2004). Cancer Res., 64, 1209–1214.

  • Jones PL and Jones FS . (2000). Matrix Biol., 19, 581–596.

  • Jung A, Schrauder M, Oswald U, Knoll C, Sellberg P, Palmqvist R, Niedobitek G, Brabletz T and Kirchner T . (2001). Am. J. Pathol., 159, 1613–1617.

  • Kirchner T and Brabletz T . (2000). Am. J. Pathol., 157, 1113–1121.

  • Kodjabachian L, Dawid IB and Toyama R . (1999). Dev. Biol., 213, 231–245.

  • Rosin-Arbesfeld R, Cliffe A, Brabletz T and Bienz M . (2003). EMBO J., 22, 1101–1113.

  • Rowan AJ, Lamlum H, Ilyas M, Wheeler J, Straub J, Papadopoulou A, Bicknell D, Bodmer WF and Tomlinson IP . (2000). Proc. Natl. Acad. Sci. USA, 97, 3352–3357.

  • Shirasaki F, Makhluf HA, LeRoy C, Watson DK and Trojanowska M . (1999). Oncogene, 18, 7755–7764.

  • Tetsu O and McCormick F . (1999). Nature, 398, 422–426.

  • Verma UN, Surabhi RM, Schmaltieg A, Becerra C and Gaynor RB . (2003). Clin. Cancer Res., 9, 1291–1300.

Download references

Acknowledgements

This work was supported by the Wilhelm Sander-Stiftung (Az.: 1999.065.2). We thank Professor Amann for kindly providing her digital photosystem.

Author information

Author notes

  1. Katharina Beiter

    Present address: Swedish Institute for Infectious Disease Control, S-17182, Solna, Sweden

Authors and Affiliations

  1. Pathologisch-Anatomisches Institut, Friedrich-Alexander-Universität Erlangen-Nürnberg, Krankenhausstr, 8-10, D-91054, Erlangen, Germany

    Katharina Beiter, Elke Hiendlmeyer, Thomas Brabletz, Falk Hlubek, Angela Haynl, Claudia Knoll, Thomas Kirchner & Andreas Jung

Authors
  1. Katharina Beiter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elke Hiendlmeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas Brabletz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Falk Hlubek
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Angela Haynl
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Claudia Knoll
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Thomas Kirchner
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Andreas Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas Jung.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beiter, K., Hiendlmeyer, E., Brabletz, T. et al. β-Catenin regulates the expression of tenascin-C in human colorectal tumors. Oncogene 24, 8200–8204 (2005). https://doi.org/10.1038/sj.onc.1208960

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208960

Keywords

This article is cited by

Search

Advanced search

Quick links